Brief: SCHOTT Pharma Says Q1 Revenue EUR 240.2 Million
11/02/2026 06:04
Feb 11 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE: SCHOTT PHARMA WITH POSITIVE START TO FINANCIAL YEAR 2026; OUTLOOK CONFIRMED Q1 2026 REVENUE UP 4.8% TO EUR 240.2 MILLION Q1 2026 EBITDA MARGIN AT 27.1% CONFIRMS 2026 FINANCIAL YEAR OUTLOOK Q1 2026 CASH FLOW DOWN TO EUR 3.4 MILLION Q1 2026 CAPEX AT EUR 23.4 MILLION Q1 EBITDA AMOUNTED TO EUR 65.2 MILLION Source text: ID:nEQ8fn6sZa Further company coverage: 1SXP.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))